Therapeutic approaches that preserve vascular stability or focus on the molecular mechanisms (e.g., CXCR4, E-selectin) which hold dormant cells could stop metastatic relapse by maintaining disseminated tumor cells (DTCs) in a dormant state or enhancing their responsiveness to treatment. This evidence concerns the gene CXCR4 and neoplasm.